These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18638229)

  • 1. Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis.
    Lucas A; Belinchón I; Pérez-Crespo M; Mataix J; Betlloch I
    Australas J Dermatol; 2008 Aug; 49(3):173-4. PubMed ID: 18638229
    [No Abstract]   [Full Text] [Related]  

  • 2. Recalcitrant pustular psoriasis successfully treated with adalimumab.
    Alvarez AC; Rodríguez-Nevado I; De Argila D; Rubio FP; Rovira I; Torrelo A; Zambrano A
    Pediatr Dermatol; 2011; 28(2):195-7. PubMed ID: 21504452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients.
    Wolf P; Hofer A; Weger W; Posch-Fabian T; Gruber-Wackernagel A; Legat FJ
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):186-9. PubMed ID: 21729166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis.
    Bagel J
    J Drugs Dermatol; 2011 Apr; 10(4):366-71. PubMed ID: 21455546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psoriasis with adalimumab.
    Pitarch G; Sanchez-Carazo JL; Mahiques L; Perez-Ferriols MA; Fortea JM
    Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis.
    Roussaki-Schulze AV; Kouskoukis C; Klimi E; Zafiriou E; Galanos A; Rallis E
    Drugs Exp Clin Res; 2005; 31(5-6):169-74. PubMed ID: 16425972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
    Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
    Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.
    Noda S; Mizuno K; Adachi M
    J Dermatol; 2012 Mar; 39(3):265-8. PubMed ID: 22126280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy.
    Shibata S; Tada Y; Hau C; Tatsuta A; Yamamoto M; Kamata M; Karakawa M; Asano Y; Mitsui H; Sugaya M; Kadono T; Saeki H; Kanda N; Sato S
    Br J Dermatol; 2011 Mar; 164(3):667-70. PubMed ID: 21062267
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study.
    Carrozza P; Häusermann P; Nestle FO; Burg G; Böni R
    Dermatology; 2000; 200(1):35-9. PubMed ID: 10681611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe facial psoriasis with adalimumab.
    Noiles K; Vender R
    J Drugs Dermatol; 2008 Dec; 7(12):1165-7. PubMed ID: 19137771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study.
    Strober BE; Poulin Y; Kerdel FA; Langley RG; Gu Y; Gupta SR; Okun MM; Papp KA
    J Am Acad Dermatol; 2011 Apr; 64(4):671-81. PubMed ID: 21414495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.
    Leonardi C; Langley RG; Papp K; Tyring SK; Wasel N; Vender R; Unnebrink K; Gupta SR; Valdecantos WC; Bagel J
    Arch Dermatol; 2011 Apr; 147(4):429-36. PubMed ID: 21173304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction: adalimumab in the treatment of psoriasis].
    Ferrándiz C; García-Díez A
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 3():1-2. PubMed ID: 18680683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of adalimumab].
    Casado M
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 3():10-4. PubMed ID: 18680685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.
    Lecluse LL; Driessen RJ; Spuls PI; de Jong EM; Stapel SO; van Doorn MB; Bos JD; Wolbink GJ
    Arch Dermatol; 2010 Feb; 146(2):127-32. PubMed ID: 20157022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy during adalimumab use for psoriasis.
    Dessinioti C; Stefanaki I; Stratigos AJ; Kostaki M; Katsambas A; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):738-9. PubMed ID: 20569288
    [No Abstract]   [Full Text] [Related]  

  • 19. Adalimumab vs. etanercept in psoriasis.
    Downs AM
    Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.